Search Within

Alexander Noor Shoushtari

  1. "Biostatistics Service"
Formats
  1. Journal Article (29)
  2. Meeting Abstract (21)
  3. Research Letter (5)
Groups
  1. Biostatistics Service (55)
  2. Department of Medicine (55)
  3. Epidemiology and Biostatistics (55)
  4. Hematologic Malignancies, Division of (55)
  5. Melanoma Disease Management Team (55)
  6. Melanoma and Immunotherapeutics Service (55)

More Groups

People
  1. Michael Postow (35)
  2. Katherine Panageas (34)
  3. Paul Chapman (29)
  4. Jedd Wolchok (28)
  5. Margaret Callahan (24)
  6. Parisa Momtaz (20)

More People

Years
  1. 2025 (2)
  2. 2024 (6)
  3. 2023 (5)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (6)

More Years

Publications
  1. Journal of Clinical Oncology (19)
  2. Clinical Cancer Research (4)
  3. JAMA Oncology (4)
  4. Annals of Surgical Oncology (3)
  5. Journal for ImmunoTherapy of Cancer (2)
  6. Melanoma Research (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (20)
  2. Springer (6)
  3. Nature Publishing Group (5)
  4. American Association for Cancer Research (4)
  5. American Medical Association (4)
  6. Elsevier Inc. (4)

More Publishers

Results (55)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors
    Journal Article

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; Tixier, F.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; more...
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Responders to anti-PD1 therapy: Long-term outcomes and responses to retreatment in melanoma (mel)
    Meeting Abstract

    Warner, A. B.; Palmer, J. S.; Shoushtari, A. N.; Goldman, D. A.; Panageas, K.; Callahan, M. K.; Wolchok, J. D.; Postow, M. A.; Chapman, P. B.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Characterization of complete responders to combination nivolumab (nivo) and ipilimumab (ipi) in patients (pts) with advanced, unresectable melanoma
    Meeting Abstract

    Warner, A. B.; Shoushtari, A. N.; Houghton, S.; Panageas, K.; Chapman, P. B.; Wolchok, J. D.; Postow, M. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MRI texture features and outcomes to immune checkpoint inhibitors in melanoma brain metastases
    Meeting Abstract

    Bhatia, A.; Birger, M.; Veeraraghavan, H.; Um, H.; McKenney, A. S.; Cugliari, M.; Caviasco, A.; Bialczak, A.; Malani, R.; Zhang, Z.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma
    Journal Article

    Rosner, S.; Kwong, E.; Shoushtari, A. N.; Friedman, C. F.; Betof, A. S.; Brady, M. S.; Coit, D. G.; Callahan, M. K.; Wolchok, J. D.; Chapman, P. B.; more...
    Cancer Medicine (2018)

    Fulltext@MSK | Save
  • Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma
    Journal Article

    Shoushtari, A. N.; Friedman, C. F.; Navid-Azarbaijani, P.; Postow, M. A.; Callahan, M. K.; Momtaz, P.; Panageas, K. S.; Wolchok, J. D.; Chapman, P. B.
    JAMA Oncology (2018)

    Fulltext@MSK | Save